Skip to main content
Cachet Pharmaceutical Co., Ltd. logo

Cachet Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 002462 ISIN · CNE100000SN0 LEI · 300300CBONJS7HUOCX64 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,441 across all filing types
Latest filing 2022-03-29 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 002462

About Cachet Pharmaceutical Co., Ltd.

https://www.cachet.com.cn

Cachet Pharmaceutical Co., Ltd. specializes in the distribution and retail of pharmaceutical products and medical devices. The company operates an extensive wholesale network and a chain of retail pharmacies, providing comprehensive supply chain solutions to healthcare institutions and end-consumers. Its core operations include the procurement, storage, and logistics of western medicines, traditional Chinese medicines, and high-value medical consumables. Cachet Pharmaceutical emphasizes modern logistics management and professional pharmaceutical services, leveraging a robust distribution infrastructure to ensure the efficient delivery of healthcare products. The company also focuses on hospital supply chain integration and community-based retail services to enhance healthcare accessibility.

Recent filings

Filing Released Lang Actions
2021年度内部控制规则落实自查表
Audit Report / Information Classification · 95% confidence The document is titled as a "2021年度内部控制规则落实自查表" which translates to "2021 Annual Internal Control Rules Implementation Self-Inspection Form." It is a detailed internal control checklist/report covering various internal audit operations, information disclosure controls, insider trading controls, fundraising controls, related party transactions, external guarantees, major investments, and other important matters. The document is structured as a self-assessment or internal control compliance report rather than a financial statement or earnings release. It does not contain financial statements or earnings highlights, nor does it announce any voting results or management changes. It is not a presentation or a call transcript. The document is a regulatory compliance report related to internal controls and audit processes, which fits best under the category of Audit Report / Information (AR). The document length is 3605 characters, which is relatively short but contains substantive internal control audit information, not just an announcement or certification. Therefore, it is classified as AR with high confidence.
2022-03-29 Chinese
董事会决议公告
Regulatory Filings Classification · 95% confidence The document is a detailed announcement of resolutions passed at the 17th meeting of the 6th Board of Directors of 嘉事堂药业股份有限公司. It includes approvals of various reports such as the 2021 Board Work Report, 2021 Operating Summary, 2021 Internal Control Self-Evaluation Report, 2021 Financial Statements, 2021 Profit Distribution Plan, 2021 Annual Report and its summary, 2021 Social Responsibility Report, and other related matters. However, the document itself does not contain the full reports but refers to them being available on the official disclosure website (巨潮资讯网) and newspapers. The document is relatively short (3631 characters) and primarily serves as a formal announcement of board meeting resolutions and references to where the full reports can be found. According to the "Menu vs Meal" rule, this is an announcement of reports and meeting resolutions rather than the reports themselves. Therefore, the appropriate classification is Regulatory Filings (RNS), as it is a general regulatory announcement of board meeting decisions and references to reports rather than the reports themselves.
2022-03-29 Chinese
年度关联方资金占用专项审计报告
Audit Report / Information Classification · 95% confidence The document is a special explanation and summary table regarding non-operating fund occupation and other related party fund transactions for the year 2021 by 嘉事堂药业股份有限公司. It includes detailed financial data and tables about fund balances, transactions, and related party relationships. The document references an audit report issued by 安永华明会计师事务所 dated March 28, 2022, but this document itself is not the full audit report; rather, it is a supplementary explanation and detailed disclosure related to regulatory requirements on fund occupation and related party transactions. It contains substantive financial data and detailed tables, not just an announcement or certification. This type of document aligns with the category of Audit Report / Information (AR), which includes standalone audit-related reports and disclosures about accounting principles and regulatory requirements, excluding full annual reports. The document is not an Annual Report (10-K), nor a Regulatory Filing (RNS) or Report Publication Announcement (RPA), as it contains detailed financial data and is not merely an announcement or certification. Therefore, the best classification is AR with high confidence.
2022-03-29 Chinese
关于举办2021年年度报告网上业绩说明会的通知公告
AGM Information Classification · 95% confidence The document is a notice announcing the holding of an online performance explanation meeting for the 2021 annual report. It mentions the approval and publication of the 2021 annual report but does not contain the report itself or detailed financial data. The document invites investors to participate in the online meeting and submit questions. The length is short (833 characters), and it serves as an announcement rather than the report or transcript itself. Therefore, it fits the category of AGM Information (AGM-R) as it relates to materials shared during an annual meeting event, specifically an annual performance explanation meeting.
2022-03-29 Chinese
内部控制自我评价报告
Audit Report / Information Classification · 95% confidence The document is titled '2021年度内部控制自我评价报告' which translates to '2021 Annual Internal Control Self-Evaluation Report'. It discusses the company's internal control system, evaluation of internal control effectiveness, risk assessment, internal audit, governance structure, and compliance with relevant regulations. The document is detailed and contains substantive content about internal control evaluation, including defect recognition standards and conclusions about the absence of major defects. It is not a general annual report or earnings release but a specialized report focused on internal control evaluation. This fits the definition of an Audit Report / Information (AR), which includes standalone audit reports and internal control evaluation results. The document length (9518 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR with high confidence.
2022-03-29 Chinese
2021年年度报告摘要
Annual Report Classification · 95% confidence The document is titled as the 2021 annual report summary of 嘉事堂药业股份有限公司, indicating it is a summary of the full annual report. It contains detailed financial data for the year 2021, including main accounting data, financial indicators, quarterly data, shareholder information, and business overview. The length is substantial (15,000 characters), and it includes comprehensive financial and operational information typical of an annual report. There is no indication that this is merely an announcement or a certification. Therefore, this document fits the definition of an Annual Report (10-K).
2022-03-29 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.